Journey Strategic Wealth LLC Astrazeneca PLC Transaction History
Journey Strategic Wealth LLC
- $2.65 Billion
- Q4 2024
A detailed history of Journey Strategic Wealth LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Journey Strategic Wealth LLC holds 7,053 shares of AZN stock, worth $476,712. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,053
Previous 7,873
10.42%
Holding current value
$476,712
Previous $613,000
24.63%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,378Shares Held
476MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.08 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.77 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.54 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.62 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.32 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $209B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...